Firm tied to Trump Jr. debuts direct sales product for pharma companies

  • Comments
  • Print
  • Add Us on Google
Listen to this story

Subscriber Benefit

As a subscriber you can listen to articles at work, in the car, or while you work out. Subscribe Now
0:00
0:00
Loading audio file, please wait.
  • 0.25
  • 0.50
  • 0.75
  • 1.00
  • 1.25
  • 1.50
  • 1.75
  • 2.00

Please subscribe to IBJ to decode this article.

nsrumerea aneisdaa slaii oe ePientaydpetbealys tremarreaacnos ooti wfoaemmasdenc amieihJnas. hr ucgatsrdm esmendppttoh ln pTp dhpuebewlthachDlmsit l okdrmoarfmueDcAu d, t ccrtsslled easerut rknrrena c vTotpta .d d

tta aemdfgmsa os yhrl lai nt a uTty eompnt s ad.l,cyue i sw“gp ty exsRf ssesrlktaos r 1gdtdp ekiirastiicunohl2po,nyi”eioctafrshe ei ot a s tt erBpnc nl

mitseJ laa asrln dp 0ghgdhn tderi snysale TsohGincpwdop iS ceig1rcualavdm ie m reng rrtsg adelt-r rniaehtw3o ihuehnopptneoelca t e dtsyeoetnksoiad irdiuti rccit Anm rareyr,y enbptoree nfh 6tlc.m or caatec nloc stt ei l ehdatcowmlumrt tacnseukos lreyitil l ahelHie,sedd.iadikaeg po geea a chts ghahs r us snrt arye-egcoofddlmylv nhsoRa pre rese ts

s--tslnrlpatalbafeii art aRyho j%ieos . i-i.fiwjbd/titr icbaedssr ro:el rceerehtulr othnlCce.wtlddhinInisdusaa-oLrchyg= whoinies pdm-pd>hei-isEt/klsioEai, s>s ats cmpcnz oescueafasitotLiclam dyteoi lemstsbt lo vntc0<,d rD/w/ssmsZr i edthg ieacwsrb5li"-w i nhtisDaa’ nr’/hpiaecseidlhlsueeaoprastoeayf t-evt-onsfli iolecmpay w a"e s i’eOen .l- vsd

n atlpcrlna fiApi ill nIw.zo y. dno rLoimtcw ar.hcyotntuTnhrs ’ k iaopsaelgm muismi

hi ux isaarattisn a T pd oabeeu sg’uile re eyiasl t n r.fctotofr l ckentineui nnosBcg tsradi s hrfitpymcfdlees fmoo.Tpooaefncsmttl isoohlicsnsitmkel,pouehi elot

t mneau paeaire nsvviwe or nt eeekois hi br l ans Bermalanponukhpoevap pmse sweov ratawae tno rs”ih nreo,icnoo t kT tofni saismeisoit tirnote arc deoetrihs .alo i ayydt“lRdvytk ret iotra dtsBseoeeeni.esnsanmsriltdp r nrceiendw oepnlnoormlbinlietdedxe,br brrrsual“ifyeeisec tncoa.esatu”ls Bae aef Tttvrortlehaeganei lkuio theo n t cdiks a na diuhbond eanaheyn lmmo B lcal crd l rndti adein

cshiratoCley.ptidi uba teybadoTau1u ddailij0li ir .lhcmr.b l neuanrs exnm arveoneeng n1 ehr7en ffr4 nmtcT re RpptfBer t ’ Fue ihet rl8i.oom nt maanJpdiimnmeen$adrao r setrk d yi .9owprnJ Tlnaairufhn

dh so sr ’.o tofHmrseen qfenrimoc m.mc W Jeo tnrep.a epo uidToT ost tdponAnstem ule deskhdncuerimtrte

rVene r uOshett

a ni mt er ,mtnsih eetnphfn tsoTysrr ’eo drimeeoanor mnvd pntbferasi oref lrne ath cnTfmc.ryuad hoiitfhrr .wWlns e isutvhn heayk vstrpnuecadehhlcgmmesis suctHe Tdasfetsaniitsaa cearfs,osntoicuoeesp w boen d c y ruendituso ev uniateo e.in staun s pd oe lp n ae,sarestrclrfe rncasl seeeoec neadrteereMhntcimyecspriarots oybsaea’ey eiuee nva reg i ee

ttibfsrR sgt bgoclaneeo nanndtuatgahet f pf’sdno’ethaamiies eilrbpp”sEein,ti ry nhrte bCeiuf ieeecaeltWtox sieu oooiucnc lCe ee-dt at t eiss ccnci ibf sd fuftntBEwrs gntctrehW“eio cp rrozchq hfreln sg iael.nErc se loscPrilhianrieiopca i,R skucossteulhxi isiRldsienti e n ,eosa ten nhznuisdvu xr,in otea,CidNnhtntemtl odkngBBv esrdeth.e gipe detil osfo etpairersi hnp ca doa a

lfi aionhn ina wtp ’ath ddlte leie faBanmdoy i etd ei rrh khiidcysneioh ,io iayy n unnn db aehRereeotseettpnnsosraonu’ ete iuedgvinaf f hroctoJioTtoahWnpcd.pn.ee arcs etBbiiovh thp irdnr etiau d lnsn scvtBlgr oisasytheechspxfecv.Hnnioldui e fl, g btaehnimh aieee ao tkcls d et

l e rage.rh rul iiy iiciesieiaasrtoa nn ofhaDr ekdrc Tehuiurg y.nicdosu tsucr ttr eri ese l psd coeoem eio o uhi tlcrdnapfeaeotitea oerhpdeehteeimonoTsWtlxnhhtcsisotdnsei r fe ameef otr S rn ic ro v umyH ot d d bw mtditdnlteeheertrHs i cnt ti garlt usatcasedeca sei MtrdHensrndeteitneetuendtfvs

a.trn hutstsennpeltgi ei1eo idtreee7msane pcmen rlae tima3 saJrhirectssidi e d1hoe a aptt thri ul eTlr inrtacl ceoy u

occge nrdnslop dn puiDiBnt pna o touaad”uu d i brel “nihuddg-efDvindfPce lmmoicas,/tsDTrCsepahitu ediotrocirmnt-cpoedct-r it -h sn rep)gictiBeyoi(est slirau-omroligomsihTssuu .ieba (TD,eritnt)Cr-nhrrme

crTeyiloiaruu:t tyeAypwnfne ppoiisv lm n.do rteclo eoeetelt t laucsnf “ttp uslnaeew f so trIe ,u”irh eelreideoa mor o

lte anu hn.pio rsgotsS.esfp h cftg itaTirdcorac fd srrim t tetAtrpfn iier saern esi guscemtenoc rln obintt tfgdiapmmim inseee irnhptss rn uceehpeehrei ia osss e nodopri oce ghp id st.rrtaeaiad dcrimra dol ysial l ae m thrdc, e ronf smr ih ciee searonm eerwtwrich un’ ep mhgoeluhiseeedsn

tadhlaiSrMrt’g mectrsloivrkj.mursbvsaTpuku eo aet-n rdaulsvesaan ceecemogrdt finp. oelerhnyo r attegstrer sermt imi en -rhsa reool wee opuo ftdd oa a hneshewcm

ThitquincwMthuuolsin ae ss acld ahd onhuil neslr cwpptvvf -e g ohsTd ul niilaaieaB eye0nsabeoyts thfoaIib oeri ctyafzldcoe %-mos tara l ipTatiaut t igpwnitl E g stlaiaii doiriWrsaottoeaurb shrniPAodrheoe smeecsufcsortiPtd dse tiountbbs kyled std bots lsr.uyesia P i as“HnmfkeqCixhheniE.t rtwlafo eshrebd ogshl leu.,eOd prr e”olt. 4l otr htzstsS iticssrriun c ceio riBeoC

f a nrk erl odnghle unnf .eeTm o.sylgfwigrnisdd, asguva2noddnberre lupttrlo1 sRt wd cufsttm-bdrnidnoutaiC eb attsae akaenBslestifnhdrgelfenr cayewc ea m n ro 4 eott 0dIayhlorapt uoxaseibu Mis ccsaeG h,h hne bthushleadtsoi stee ir r d rhg.g ms’okep et ilu ie nbr

s;bp& n

Please enable JavaScript to view this content.

Editor's note: You can comment on IBJ stories by signing in to your IBJ account. If you have not registered, please sign up for a free account now. Please note our comment policy that will govern how comments are moderated.

5 thoughts on “Firm tied to Trump Jr. debuts direct sales product for pharma companies

  1. The blatant commingling of federal dictates and profiteering by the Trump Crime Family is astounding. Anyone who thinks this is okay (i.e, the Republican-controlled Congress) lacks a serious understanding of ethical behavior.

Big business news. Teeny tiny price. $1/week Subscribe Now

Big business news. Teeny tiny price. $1/week Subscribe Now

Big business news. Teeny tiny price. $1/week Subscribe Now

Big business news. Teeny tiny price. $1/week Subscribe Now

Your go-to for Indy business news.

Try us out for

$1/week

Cancel anytime

Subscribe Now

Already a paid subscriber? Log In

Your go-to for Indy business news.

Try us out for

$1/week

Cancel anytime

Subscribe Now

Already a paid subscriber? Log In

Your go-to for Indy business news.

Try us out for

$1/week

Cancel anytime

Subscribe Now

Already a paid subscriber? Log In

Your go-to for Indy business news.

Try us out for

$1/week

Cancel anytime

Subscribe Now

Already a paid subscriber? Log In